Victory Capital Management
TARS icon

Victory Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Victory Capital Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Buy
4,667
+96
+2% +$6.13K ﹤0.01% 2175
2026
Q1 		$321K Buy
4,571
+66
+1% +$4.61K ﹤0.01% 2115
2025
Q4 		$369K Buy
4,505
+62
+1% +$4.63K ﹤0.01% 2084
2025
Q3 		$264K Sell
4,443
-57,792
-93% -$2.85M ﹤0.01% 2168
2025
Q2 		$2.52M Buy
62,235
+17,915
+40% +$806K ﹤0.01% 1525
2025
Q1 		$2.28M Buy
44,320
+40,289
+999% +$1.99M ﹤0.01% 1493
2024
Q4 		$223K Buy
+4,031
New +$183K ﹤0.01% 2206

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Victory Capital Management's TARS Position: Q2 2026 in Review

Victory Capital Management increased its Tarsus Pharmaceuticals (TARS) stake by 2.1% in Q2 2026, buying an estimated $6.13K and bringing the position to 4,667 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #2175.

Victory Capital Management first reported a position in TARS in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.52M in Q2 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Victory Capital Management held 4,667 shares of Tarsus Pharmaceuticals worth $294K as of Q2 2026.
  • Victory Capital Management bought 96 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $6.13K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2175 holding.
  • Victory Capital Management first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Victory Capital Management's Tarsus Pharmaceuticals position peaked at $2.52M in Q2 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.